Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TRACON starts phase I/II TRC-105 trial in prostate cancer

April 28, 2010

FDA clears NexMed's phase II PrevOnco trial in advanced unresectable hepatocellular cancer

April 28, 2010

Cleveland BioLabs opens U.S. office of Incuron to develop anticancer curaxins

April 28, 2010

Cancer cell stemness inhibitor BBI-608 safe and active in ongoing phase I trial

April 28, 2010

Exelixis claims novel mTOR and PI3K-alpha inhibitors

April 28, 2010

Proteo completes patient recruitment in phase II Elafin trial

April 27, 2010

CHMP recommends conditional marketing approval for Votrient

April 27, 2010

Oncolytics Biotech completes phase I enrollment for phase I/II Reolysin trial

April 27, 2010

Temozolomide shows activity in pituitary tumors and carcinomas

April 27, 2010

Telik presents novel Aurora A/B and VEGFR-2 inhibitors

April 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...